Vendor, Carlsbad, CA
Arisan Therapeutics Inc.
UEI PYRKTQPNVJZ8, CAGE 616D2
1 award and $2,933,547 obligated between July 29, 2026 and July 29, 2026, 100% under full and open competition, against 20.0 offers on average where reported. 3 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $2,933,547 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93026C00012Definitive Contract, July 29, 2026, Full and Open Competition, 20 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | To Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection.NAICS 541715, PSC AN12 | $2,933,547 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards